
0.0218 Delayed Data As of Jun 02 | ![]() Today’s Change | 0.01 Today|||52-Week Range 1.57 | -87.54% Year-to-Date |
SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $2.0M |
Rubius Therapeutics, Inc. 124 Washington Street Foxboro Massachusetts 02035 |
Craig R. Jalbert | President, Treasurer, Secretary & Director |
James Jogerst | Chief Business Officer |
Lori Murray | Chief Corporate Affairs Officer |
Tamyra A. Toole | Vice President-Regulatory Affairs |